摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(3-fluorophenyl)-3-methylisoxazolo[3,4-d]pyridazin-7(6H)-one | 627501-25-1

中文名称
——
中文别名
——
英文名称
4-(3-fluorophenyl)-3-methylisoxazolo[3,4-d]pyridazin-7(6H)-one
英文别名
4-(3-fluorophenyl)-3-methyl-6H-[1,2]oxazolo[3,4-d]pyridazin-7-one
4-(3-fluorophenyl)-3-methylisoxazolo[3,4-d]pyridazin-7(6H)-one化学式
CAS
627501-25-1
化学式
C12H8FN3O2
mdl
MFCD16991142
分子量
245.213
InChiKey
XCWYCSBNMOEJTQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    18
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    67.5
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    4-(3-fluorophenyl)-3-methylisoxazolo[3,4-d]pyridazin-7(6H)-one 、 alkaline earth salt of/the/ methylsulfuric acid 在 potassium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以85%的产率得到6-benzyl-4-(3-fluorophenyl)-3-methylisoxazolo[3,4-d]pyridazin-7(6H)-one
    参考文献:
    名称:
    Pyrazolo[1′,5′:1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A1 adenosine receptor ligands
    摘要:
    A series of pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones was synthesized and tested in radio-ligand binding assays to determine their affinities for the human adenosine A(1), A(2A), A(2B) and A(3) receptors. Results indicated that this scaffold is appropriate for adenosine receptor subtype A1 ligands and that the best arranged groups around this scaffold are 3- and 4-pyridinyl at position 1, benzyl at position 3, hydrogen at position 6 and 3- thienyl or phenyl at position 9. The most interesting compounds showed K-i for A1 in the nanomolar range and an appreciable selectivity for other receptor subtypes. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2010.09.043
点击查看最新优质反应信息

文献信息

  • [EN] NEW PYRIDAZIN-3(2H)-ONE DERIVATIVES<br/>[FR] NOUVEAUX DERIVES DE PYRIDAZIN-3(2H)-ONE
    申请人:ALMIRALL PRODESFARMA SA
    公开号:WO2004058729A1
    公开(公告)日:2004-07-15
    Pyridazin-3(2H)-one derivatives of formula (I) are found to inhibit PDE-4:, wherein R1, R2 and R4 are organic radicals, R3 is a cyclic group, and R5 is an ester or an aryl or heteroaryl group.
    式(I)的吡啶嗪-3(2H)-酮衍生物被发现能抑制PDE-4:其中R1、R2和R4为有机基团,R3为环状基团,R5为酯基或芳基或杂芳基。
  • [EN] PYRIDAZIN-3(2H)-ONE DERIVATIVES AS PDE4 INHIBITORS<br/>[FR] DERIVES DE LA PYRIDAZINE-3(2h)-ONE, INHIBITEURS DE LA PDE4
    申请人:ALMIRALL PRODESFARMA SA
    公开号:WO2003097613A1
    公开(公告)日:2003-11-27
    New pyridazin-3(2H)-one derivatives having the chemical structure of general formula (I); are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of phosphodiesterase 4.
    新的吡啶并嗪-3(2H)-酮衍生物具有一般式(I)的化学结构;公开了它们的制备方法,包括它们的药物组合物以及它们作为磷酸二酯酶4抑制剂在治疗中的用途。
  • New pyridazin-3(2h)-one derivatives
    申请人:Dal Piaz Vittorio
    公开号:US20060173008A1
    公开(公告)日:2006-08-03
    Pyridazin-3(2H)-one derivatives of formula (I) are found to inhibit PDE-4. R 1 , R 2 and R 4 are organic radicals, R 3 is a cyclic group, and R 5 is an ester or an aryl or heteroaryl group.
    公式(I)的吡啶并嗪-3(2H)-酮衍生物被发现可以抑制PDE-4。R1,R2和R4是有机基团,R3是一个环状基团,R5是酯基或芳基或杂环基团。
  • Pyridazin-3(2h)-one derivatives as pde4 inhibitors
    申请人:Dal Piaz Vittorio
    公开号:US20060052379A1
    公开(公告)日:2006-03-09
    New pyridazin-3(2H)-one derivatives having the chemical structure of general formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of phosphodiesterase 4.
    本发明公开了具有一般式(I)化学结构的新吡啶并嗪-3(2H)-酮衍生物;以及其制备过程、包含它们的制药组合物以及它们作为磷酸二酯酶4抑制剂在治疗中的应用。
  • PYRIDAZIN-3 (2H) -ONE DERIVATIVES AS PDE4 INHIBITORS
    申请人:Dal Piaz Vittorio
    公开号:US20080269235A1
    公开(公告)日:2008-10-30
    New pyridazin-3(2H)-one derivatives having the chemical structure of general formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of phosphodiesterase 4.
    本发明揭示了具有一般式(I)的化学结构的新吡啶并嗪-3(2H)-酮衍生物,以及它们的制备方法、含有它们的药物组合物以及它们作为磷酸二酯酶4抑制剂在治疗中的使用。
查看更多